Table 3.

Associations between GLR or mGPS and OS in patients with NSCLC.

Variables	Patients (n)	Crude HR (95% CIs)	P-value	Adjusted HR (95% CIs)	P-value
GLR a
Continuous	862	1.038 (1.013, 1.063)	0.002	1.029 (1.004, 1.056)	0.023
Categories b
Low	604	Reference		Reference
High	258	1.691 (1.408, 2.030)	<0.001	1.501 (1.246, 1.808)	<0.001
Quartiles
1	215	Reference		Reference
2	216	1.147 (0.884, 1.487)	0.302	1.122 (0.864, 1.457)	0.388
3	216	1.249 (0.966, 1.615)	0.089	1.185 (0.914, 1.536)	0.199
4	215	1.877 (1.468, 2.400)	<0.001	1.662 (1.292, 2.138)	<0.001
mGPS c
0	507	Reference		Reference
1	254	1.723 (1.406, 2.111)	<0.001	1.404 (1.143, 1.726)	0.001
2	101	2.021 (1.559, 2.621)	<0.001	1.515 (1.159, 1.980)	0.002
GLR and mGPS d
Low GLR and 0 score	382	Reference		Reference
High GLR and 0 score	125	1.790 (1.371, 2.336)	<0.001	1.564 (1.220, 2.006)	<0.001
Low GLR and 1 score	157	2.024 (1.590, 2.577)	<0.001	1.499 (1.153, 1.948)	0.002
High GLR and 1 score	97	2.477 (1.878, 3.267)	<0.001	1.910 (1.413, 2.583)	<0.001
Low GLR and 2 score	65	2.077 (1.482, 2.912)	<0.001	1.425 (1.014, 2.003)	0.042
High GLR and 2 score	36	3.686 (2.485, 5.467)	<0.001	2.554 (1.705, 3.824)	<0.001

GLR, blood glucose to lymphocyte ratio; mGPS, modified Glasgow prognostic score; OS, overall survival; NSCLC, non-small cell lung cancer; HR, hazard ratio; CIs, confidence intervals.

^aModels were adjusted for sex, age, body mass index, tea drinking status, TNM stage and mGPS.

^bThe cut-off point of GLR is 4.726.

^cModel was adjusted for sex, age, body mass index, tea drinking status, TNM stage and GLR (as a continuous variable).

^dModel was adjusted for sex, age, body mass index, tea drinking status and TNM stage.